I am a consultant clinical geneticist and clinician scientist with a research focus on human genetics. In 2016 I was appointed to the position of inaugural Pamela and Lorenzo Galli Chair in Developmental Medicine, with a specific research and clinical focus on the causes of intellectual and physical disability.
I completed RACP training in paediatrics and clinical genetics in 2000 before undertaking PhD studies in chromosome biology completed in 2004. Since 2005 I have worked as a consultant clinical geneticist at Victorian Clinical Genetics Services (VCGS) and as a Research Group leader at Murdoch Children’s Research Institute (MCRI). From 2009 to 2016 I was Director of Victorian Clinical Genetics Services.
I am a consultant clinical geneticist and clinician scientist with a research focus on human genetics. In 2016 I was appointed to the position of inaugural Pamela and Lorenzo Galli Chair in Developmental Medicine, with a specific research and...
I am a consultant clinical geneticist and clinician scientist with a research focus on human genetics. In 2016 I was appointed to the position of inaugural Pamela and Lorenzo Galli Chair in Developmental Medicine, with a specific research and clinical focus on the causes of intellectual and physical disability.
I completed RACP training in paediatrics and clinical genetics in 2000 before undertaking PhD studies in chromosome biology completed in 2004. Since 2005 I have worked as a consultant clinical geneticist at Victorian Clinical Genetics Services (VCGS) and as a Research Group leader at Murdoch Children’s Research Institute (MCRI). From 2009 to 2016 I was Director of Victorian Clinical Genetics Services.
Top Publications
McClaren, BJ, Aitken, M, Massie, J, Amor, D, Ukoumunne, OC, Metcalfe, SA.
Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing.
Genetics in Medicine
15(7)
:
533 -540
2013
view publication
Heath, JA, Ng, J, Beshay, V, Coleman, L, Lo, P, Amor, DJ.
Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.
Pediatric Blood & Cancer
60(6)
:
e13 -e15
2013
view publication
Risheg, H, Pasion, R, Sacharow, S, Proud, V, Immken, L, Schwartz, S, Tepperberg, JH, Papenhausen, P, Tan, TY, Andrieux, J, et al.
Clinical Comparison of Overlapping Deletions of 19p13.3.
American Journal of Medical Genetics Part A
161(5)
:
1110 -1116
2013
view publication
Godler, DE, Inaba, Y, Shi, EZ, Skinner, C, Bui, QM, Francis, D, Amor, DJ, Hopper, JL, Loesch, DZ, Hagerman, RJ, et al.
Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty.
Human Molecular Genetics
22(8)
:
1516 -1524
2013
view publication
Inaba, Y, Herlihy, AS, Schwartz, CE, Skinner, C, Bui, QM, Cobb, J, Shi, EZ, Francis, D, Arvaj, A, Amor, DJ, et al.
Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study.
Genetics in Medicine
15(4)
:
290 -298
2013
view publication